EUVIMEDEUVIMED entdecken
Crossref

A 19 F MRI/NIR‐FL Nanoprobe for “Turn‐On” Imaging of β‐Secretase (BACE1) Activity in Alzheimer's Disease

Lingling Xu, Qiaochu Jiang, Yuanyuan Jin, Tianyu Lin, Ruijie Cao, Hai‐Dong Xu, Xiaoyang Liu, Zhanjun Yang, Wenjun Zhan, Gaolin Liang

Angewandte Chemie · 20.07.2026 · 138 (30)

DOI: 10.1002/ange.1325073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 08.06.2026. Verfasst von Lingling Xu und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common progressive neurodegenerative disorder with very few therapeutic methods; thus, its early detection is urgently important. β‐secretase (BACE1) is a well‐recognized biomarker of early‐stage AD, but its in vivo imaging‐based diagnostic method is rarely reported. Herein, we report a BACE1‐disassemblable nanoprobe, 19 F‐Cy5.5‐NP for “Turn‐On” 19 F magnetic resonance/near‐infrared fluorescence ( 19 F MR/NIR‐FL) imaging of the enzyme activity in AD in vivo. The “Turn‐On” 19 F MRI signals are employed for imaging BACE1 activity with high specificity, while the “Turn‐On” NIR‐FL signals are used for double checking the enzyme activity with high spatial resolution. Specifically, 19 F‐Cy5.5‐NP, with a silent 19 F MR/NIR‐FL signal is obtained from the precursor Cys(StBu)‐Glu‐Val‐Asn‐Leu‐Asp‐Ala‐Glu‐Phe(CF 3 )‐Lys(Cy5.5)‐CBT ( 19 F‐Cy5.5 ) through a CBT‐Cys click reaction. Upon BACE1 cleavage, the nanoprobe disassembles, resulting in 6.8 ± 1.3‐fold and 9.5 ± 0.3‐fold increases of 1 9 F NMR and NIR‐FL signals in vitro, respectively. Moreover, 19 F‐Cy5.5‐NP renders 4.6 ± 0.9‐fold/1.5 ± 0.1‐fold higher 19 F MRI/NIR‐FL signal in Aβ 25–35 ‐treated PC12 cells than that in normal PC12 cells. In vivo experimental results show that this nanoprobe enables the precise imaging of BACE1 activity in AD zebrafish models. We anticipate that 19 F‐Cy5.5‐NP could be applied for the early diagnosis of AD in clinics in the future.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Xu, L., Jiang, Q., Jin, Y., Lin, T., Cao, R., Xu, H., Liu, X., Yang, Z., Zhan, W., & Liang, G. (2026). A 19 F MRI/NIR‐FL Nanoprobe for “Turn‐On” Imaging of β‐Secretase (BACE1) Activity in Alzheimer's Disease. Angewandte Chemie, 138(30). https://doi.org/10.1002/ange.1325073

Vancouver

Xu L, Jiang Q, Jin Y, Lin T, Cao R, Xu H, et al. A 19 F MRI/NIR‐FL Nanoprobe for “Turn‐On” Imaging of β‐Secretase (BACE1) Activity in Alzheimer's Disease. Angewandte Chemie. 2026;138(30). doi:10.1002/ange.1325073

BibTeX
@article{Xu2026,
  author = {Xu, Lingling and Jiang, Qiaochu and Jin, Yuanyuan and Lin, Tianyu and Cao, Ruijie and Xu, Hai‐Dong and Liu, Xiaoyang and Yang, Zhanjun and Zhan, Wenjun and Liang, Gaolin},
  title = {A 19 F MRI/NIR‐FL Nanoprobe for “Turn‐On” Imaging of β‐Secretase (BACE1) Activity in Alzheimer's Disease},
  journal = {Angewandte Chemie},
  year = {2026},
  volume = {138},
  number = {30},
  doi = {10.1002/ange.1325073}
}
Kostenlos starten →